Evidence map›Paper›PMID 37421318›Full record

ArticleEuropace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology2023

Implementation of a screening and management pathway for chronic obstructive pulmonary disease in patients with atrial fibrillation.

Rachel M J van der Velden, Maartje J M Hereijgers, Nazia Arman, Naomi van Middendorp, Frits M E Franssen, Monika Gawalko, Dominique V M Verhaert, Zarina Habibi, Kevin Vernooy, Lukasz Koltowski and 5 more

Open access · hybridAbstract read
In one paragraph

Article in Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
2.6field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it, 12 citations in OpenAlex.

  1. Pooled it
  2. Recent highlights from theInternational journal of cardiology. Heart & vasculature · 2026
    Article
  3. Observational
  4. Article
  5. Article
  6. Observational
  7. Impact of lifestyle risk factors on atrial fibrillation: Mechanisms and prevention approaches - A narrative review.International journal of cardiology. Cardiovascular risk and prevention · 2024
    Review
  8. Recent highlights from theInternational journal of cardiology. Heart & vasculature · 2024
    Article
  9. Longer and better lives for patients with atrial fibrillation: the 9th AFNET/EHRA consensus conference.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2024
    Article
  10. Impact of chronic obstructive pulmonary disease in patients with atrial fibrillation: an analysis from the GLORIA-AF registry.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2023
    Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 6 institutions in 5 countries.

Rachel M J van der VeldenDepartment of Cardiology, Maastricht University Medical Centre and Cardiovascular Research Institute Maastricht, P. Debyelaan 25, 6229 HX Maastricht, the Netherlands.ORCID 0000-0001-7144-3333
Maartje J M HereijgersDepartment of Cardiology, Maastricht University Medical Centre and Cardiovascular Research Institute Maastricht, P. Debyelaan 25, 6229 HX Maastricht, the Netherlands.ORCID 0000-0002-8896-6293
Nazia ArmanDepartment of Cardiology, Maastricht University Medical Centre and Cardiovascular Research Institute Maastricht, P. Debyelaan 25, 6229 HX Maastricht, the Netherlands.
Naomi van MiddendorpDepartment of Cardiology, Maastricht University Medical Centre and Cardiovascular Research Institute Maastricht, P. Debyelaan 25, 6229 HX Maastricht, the Netherlands.
Frits M E FranssenDepartment of Research and Development, Ciro, 6085 NM Horn, the Netherlands.
Monika GawalkoDepartment of Cardiology, Maastricht University Medical Centre and Cardiovascular Research Institute Maastricht, P. Debyelaan 25, 6229 HX Maastricht, the Netherlands.ORCID 0000-0003-4619-9062
Dominique V M VerhaertDepartment of Cardiology, Maastricht University Medical Centre and Cardiovascular Research Institute Maastricht, P. Debyelaan 25, 6229 HX Maastricht, the Netherlands.ORCID 0000-0003-3477-2589
Zarina HabibiDepartment of Cardiology, Maastricht University Medical Centre and Cardiovascular Research Institute Maastricht, P. Debyelaan 25, 6229 HX Maastricht, the Netherlands.ORCID 0000-0002-0369-7670
Kevin VernooyDepartment of Cardiology, Maastricht University Medical Centre and Cardiovascular Research Institute Maastricht, P. Debyelaan 25, 6229 HX Maastricht, the Netherlands.ORCID 0000-0002-8818-5964
Lukasz Koltowski1st Department of Cardiology, Medical University of Warsaw, 02-091 Warsaw, Poland.ORCID 0000-0003-0477-2094
Jeroen M HendriksCaring Futures Institute, College of Nursing and Health Sciences, Flinders University, 5001 Adelaide, Australia.ORCID 0000-0003-4326-9256
Hein HeidbuchelDepartment of Cardiology, Antwerp University Hospital, 2650 Antwerp, Belgium.ORCID 0000-0001-9301-8127
Lien DestegheDepartment of Cardiology, Antwerp University Hospital, 2650 Antwerp, Belgium.ORCID 0000-0001-8641-4658
Sami O SimonsNUTRIM School of Nutrition and Translational Research in Metabolism, Maastricht University, 6200 MD Maastricht, the Netherlands.
Dominik LinzDepartment of Cardiology, Maastricht University Medical Centre and Cardiovascular Research Institute Maastricht, P. Debyelaan 25, 6229 HX Maastricht, the Netherlands.ORCID 0000-0003-4893-0824
Maastricht University Medical Centre · NLRadboud University Nijmegen · NLMedical University of Warsaw · PLUniversity of Antwerp · BERoyal Adelaide Hospital · AUUniversity of Copenhagen · DK

Funding

Dutch Heart Foundation CVON2014-09European Commission 860974
6 · The paper itself

Abstract

aimsChronic obstructive pulmonary disease (COPD) negatively impacts the efficacy of heart rhythm control treatments in patients with atrial fibrillation (AF). Although COPD is recognized as a risk factor for AF, practical guidance about how and when to screen for COPD is not available. Herein, we describe the implementation of an integrated screening and management pathway for COPD into the existing pre-ablation work-up in an AF outpatient clinic infrastructure. METHODS AND

resultsConsecutive unselected patients accepted for AF catheter ablation in the Maastricht University Medical Center+ were prospectively screened for airflow limitation using handheld (micro)spirometry at the pre-ablation outpatient clinic supervised by an AF nurse. Patients with results suggestive of airflow limitation were offered referral to the pulmonologist. Handheld (micro)spirometry was performed in 232 AF patients, which provided interpretable results in 206 (88.8%) patients. Airflow limitation was observed in 47 patients (20.3%). Out of these 47 patients, 29 (62%) opted for referral to the pulmonologist. The primary reason for non-referral was low perceived symptom burden. Using this screening strategy 17 (out of 232; 7.3%) ultimately received a diagnosis of chronic respiratory disease, either COPD or asthma.

conclusionA COPD care pathway can successfully be embedded in an existing AF outpatient clinic infrastructure, using (micro)spirometry and remote analysis of results. Although one out of five patients had results suggestive of an underlying chronic respiratory disease, only 62% of these patients opted for a referral. Pre-selection of patients as well as patient education might increase the diagnostic yield and requires further research.

Indexed as

Atrial FibrillationPulmonary Disease, Chronic ObstructiveHumansLungRisk FactorsAtrial fibrillationCare pathwayChronic obstructive pulmonary diseaseMicrospirometryScreening

Identifiers

PMID37421318
PMCPMC10351574
OpenAlexW4383602205

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.